Profile
Adam Wojciech Lukojc is currently Chief Financial Officer at Captor Therapeutics SA since 2025.
Formerly, Dr. Lukojc was Head of Equity at Allianz Polska TFI SA from 2017 to 2025, Portfolio Manager at Skarbiec TFI SA from 2012 to 2016, Portfolio Manager at Credit Suisse Asset Management Polska SA from 2009 to 2011, Portfolio Manager at IPOPEMA Asset Management SA, and Member of the Supervisory Board at Mennica Skarbowa SA. Education includes an undergraduate degree from Uniwersytet Ekonomiczny WE Wroclawiu and a doctorate from Kozminski University.
Adam Wojciech Lukojc active positions
| Companies | Position | Start |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Director of Finance/CFO | 2025-01-31 |
Former positions of Adam Wojciech Lukojc
| Companies | Position | End |
|---|---|---|
Allianz Polska TFI SA
Allianz Polska TFI SA Investment ManagersFinance Allianz Polska is an active, growth and value-oriented investment manager which pursues a long-term investment philosophy with primary research as the basis for investment decisions. The firm seeks to invest in Polish equity, government bonds and corporate bonds debt, seeking small- to mid-cap companies with solid growth prospects. The selection process is bottom-up, sector-based and supplemented by a top-down allocation. | Head-Equity Investments | 2025-01-31 |
Skarbiec TFI SA
Skarbiec TFI SA Investment ManagersFinance Skarbiec is a long-term, growth and value-oriented manager which follows a variety of investment strategies to manage their portfolios, including fixed-income, growth, balanced, -asset allocation and aggressive strategies. The firm invests across sectors and market caps in Polish equity, government bonds, real estate, fund of funds and money market instruments. Their research analysts perform in-house research, including company visits, which portfolio managers use to construct diversified portfolios. Portfolio managers make investment decisions for their funds, each of which follows a specific benchmark. | Portfolio Manager-Equities | 2016-11-30 |
Credit Suisse Asset Management Polska SA
Credit Suisse Asset Management Polska SA Investment ManagersFinance CSAM-P operates as part of CSGN, which aims to create value for shareholders by taking advantage of their global integrated network. CSGN actively manages funds across asset classes, geographic regions, sectors and strategies. Their investment philosophy is growth-oriented and research-driven, and combines a top-down approach for asset allocation with a bottom-up approach for stock selection. The firm's fixed-income portfolios cover major markets including emerging markets. They base fixed-income investments on the analysis of macroeconomic trends, currency fluctuation, credit risk, and company valuation. They also offers liquidity funds, as well as balanced products at the domestic, international and global level. | Analyst-Equity | 2011-08-31 |
| MENNICA SKARBOWA S.A. | Director/Board Member | - |
IPOPEMA Asset Management SA
IPOPEMA Asset Management SA Investment ManagersFinance IPOPEMA Asset Management manages diverse investment products including open-end and close-end funds. | Portfolio Manager-Equities | - |
Training of Adam Wojciech Lukojc
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Credit Suisse Asset Management Polska SA
Credit Suisse Asset Management Polska SA Investment ManagersFinance CSAM-P operates as part of CSGN, which aims to create value for shareholders by taking advantage of their global integrated network. CSGN actively manages funds across asset classes, geographic regions, sectors and strategies. Their investment philosophy is growth-oriented and research-driven, and combines a top-down approach for asset allocation with a bottom-up approach for stock selection. The firm's fixed-income portfolios cover major markets including emerging markets. They base fixed-income investments on the analysis of macroeconomic trends, currency fluctuation, credit risk, and company valuation. They also offers liquidity funds, as well as balanced products at the domestic, international and global level. | Finance |
Allianz Polska TFI SA
Allianz Polska TFI SA Investment ManagersFinance Allianz Polska is an active, growth and value-oriented investment manager which pursues a long-term investment philosophy with primary research as the basis for investment decisions. The firm seeks to invest in Polish equity, government bonds and corporate bonds debt, seeking small- to mid-cap companies with solid growth prospects. The selection process is bottom-up, sector-based and supplemented by a top-down allocation. | Finance |
Skarbiec TFI SA
Skarbiec TFI SA Investment ManagersFinance Skarbiec is a long-term, growth and value-oriented manager which follows a variety of investment strategies to manage their portfolios, including fixed-income, growth, balanced, -asset allocation and aggressive strategies. The firm invests across sectors and market caps in Polish equity, government bonds, real estate, fund of funds and money market instruments. Their research analysts perform in-house research, including company visits, which portfolio managers use to construct diversified portfolios. Portfolio managers make investment decisions for their funds, each of which follows a specific benchmark. | Finance |
Uniwersytet Ekonomiczny WE Wroclawiu
Uniwersytet Ekonomiczny WE Wroclawiu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kozminski University
Kozminski University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IPOPEMA Asset Management SA
IPOPEMA Asset Management SA Investment ManagersFinance IPOPEMA Asset Management manages diverse investment products including open-end and close-end funds. | Finance |
Mennica Skarbowa SA
Mennica Skarbowa SA Specialty StoresRetail Trade Sells gold and silver bullion and diamonds | Retail Trade |
Captor Therapeutics SA
Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Adam Wojciech Lukojc
















